Shares of the US advanced electronics, digital imaging, instrumentation and mission-critical supplier Teledyne Technologies (TDY.US) set a new all-time high near $510 per share. The company raised its 2025 outlook after a series of strategic acquisitions. The record quarterly sales of $1,502.3 million showed strong momentum, in defence, space and energy sectors. Wall Street anticipates that increasing defence spending as well as the new space programs may be a catalyst for overall company business, under the Donald Trump.
- Revenue: $1.50 billion vs estimates of $1.45 billion (5.4% year-on-year growth, 3.4% beat)
- Adjusted EPS: $5.52 vs estimates of $5.23 (5.6% beat)
- Adjusted EPS guidance for the upcoming financial year 2025 is $21.30 at the midpoint, missing analyst estimates by 1.2% (GAAP EPS between $17.70-$18.20)
- Operating Margin: 15.8%, down from 19.1% in the same quarter last year
- Free Cash Flow Margin: 20.2%, up from 8.7% in the same quarter last year
As for now, the company has $1.99 billion in debt, with record free cash flows at almost $1.1 billion FY free cash flow. The planned $770 million deployment for acquisitions in Q1 2025 indicates a confident expansion strategy.
- Digital Imaging (almost 2.5% growth): Strength in unmanned air systems and surveillance, though facing headwinds in X-ray and industrial automation
- Instrumentation (10% growth): Exceptional performance in marine instrumentation, driven by offshore energy and defense markets
- Aerospace and Defense Electronics (almost 7% growth): Solid defense electronics business expansion, offsetting weaker aerospace performance
Teledyne Technologies (TDY.US, H4 interval)
Source: xStation5
Tesla falls 1.30% despite record quarterly revenue 🔎
Daily wrap – US Export Restrictions on China and Weaker Earnings Trigger Wall Street Correction
Google Quantum Echoes – A Quantum Computing Breakthrough
Those Stocks Scared Investors Ahead Of This Halloween🎃 — Market Losers of 2025
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
